avapro has been researched along with Hepatitis B Virus Infection in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, S | 1 |
| Zhen, Y | 1 |
| Fu, L | 2 |
| Gao, F | 1 |
| Zhou, X | 1 |
| Huang, S | 1 |
| Zhang, L | 2 |
| Chen, S | 1 |
| Chen, Y | 1 |
| Ko, C | 1 |
| Park, WJ | 1 |
| Park, S | 1 |
| Kim, S | 1 |
| Windisch, MP | 1 |
| Ryu, WS | 1 |
| Yang, Y | 1 |
| Ma, L | 1 |
| Wang, C | 1 |
| Kong, D | 1 |
| Wang, Y | 1 |
| Mei, C | 1 |
1 review available for avapro and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interf | 2022 |
1 trial available for avapro and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Effectiveness of sulodexide might be associated with inhibition of complement system in hepatitis B virus-associated membranous nephropathy: An inspiration from a pilot trial.
Topics: Adult; Anticoagulants; Antihypertensive Agents; Antiviral Agents; Biphenyl Compounds; Complement Sys | 2016 |
2 other studies available for avapro and Hepatitis B Virus Infection
| Article | Year |
|---|---|
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.
Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis | 2019 |
The FDA-approved drug irbesartan inhibits HBV-infection in HepG2 cells stably expressing sodium taurocholate co-transporting polypeptide.
Topics: Antiviral Agents; Biphenyl Compounds; Cell Line; Cells, Cultured; DNA, Viral; Gene Expression; Hep G | 2015 |